< Back

What Is the Brand Name for Semaglutide? Ozempic, Wegovy, and Rybelsus Explained

FAQ-000101

Direct Answer

Semaglutide is the generic (active ingredient) name. It's sold under multiple brand names depending on formulation and approved use: Ozempic (injectable, for type 2 diabetes and cardiovascular risk reduction), Wegovy (injectable, for chronic weight management), and an oral tablet form, most recently marketed as the Ozempic tablet after Rybelsus was discontinued in May 2026. All contain the same active ingredient, just different doses, formulations, and approved indications.

Why Multiple Brand Names for One Drug

This naming pattern, one active ingredient, multiple brand names for different approved uses, is standard across the GLP-1 category. Tirzepatide follows the same pattern as Mounjaro and Zepbound, liraglutide as Victoza and Saxenda. Manufacturers market separately by indication since dosing, maximum dose, and target patient population genuinely differ between uses.

Quick Reference

Generic name: semaglutide. Brand names: Ozempic (injectable, diabetes), Wegovy (injectable, weight management), Ozempic tablet (oral, diabetes, replaced Rybelsus in May 2026). Drug class: GLP-1 receptor agonist.

Bottom Line

Whether you're asking about Ozempic, Wegovy, or the Ozempic tablet, you're asking about the same core active ingredient, semaglutide, marketed differently based on formulation and approved use.

References

FDA Prescribing Information: Ozempic and Wegovy

Related Resources

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. The information on DietApp.com is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

semaglutide-brand-name-ozempic-wegovy-rybelsus